Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.14 USD | -0.07% | -2.05% | +3.57% |
May. 08 | Vaxcyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 25 | Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
7.09B | - | - | - | - | - | |
109B | ||||||
105B | ||||||
22.25B | - | |||||
22.09B | - | |||||
18.68B |
- Stock Market
- Equities
- PCVX Stock
- Charts Vaxcyte, Inc.
- Sector Chart